Literature DB >> 16824931

In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.

Raúl N Ondarza1, Angelica Iturbe, Eva Hernández.   

Abstract

BACKGROUND: Using reproducible conditions in vitro, the aim of this study was to obtain a comparative evaluation of the efficacies of several tricyclic neuroleptics, antimycotics and antibiotics with antiproliferative activities against Acanthamoeba polyphaga and Naegleria fowleri trophozoites.
METHODS: We used reproducible conditions in vitro to obtain results.
RESULTS: In the case of A.polyphaga, the tricyclic neuroleptics trifluoperazine and chlorpromazine had the best inhibitory (IC50) effects followed by mepacrine, ketoconazole, pentamidine, miconazole, amphotericin B, and metronidazole. Of all, rifampicin was the least effective. Mepacrine was the most effective compound with the minimum inhibitory concentration (MIC100) against A.polyphaga [corrected] The most effective drugs against N. fowleri expressed as (IC50) were as follows: the antimycotics ketoconazole and amphotericin B, followed by trifluoperazine, mepacrine, chlorpromazine, miconazole, and metronidazole. The least effectives were rifampicin and pentamidine. The most potent growth inhibitors (MIC100) against N. fowleri were the antimycotics amphotericin B and ketoconazole and the neuroleptic trifluoperazine. It was clear that there are major differences between the two amebas in their susceptibility to some of the drugs.
CONCLUSIONS: The drugs with the minimal inhibitory concentration (MIC) values could be considered alone or in combination as potential anti-amebic agents for the treatment of the diseases produced by these amebas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824931     DOI: 10.1016/j.arcmed.2006.02.007

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  11 in total

1.  In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.

Authors:  I Heredero-Bermejo; J L Copa-Patiño; J Soliveri; R Gómez; F J de la Mata; J Pérez-Serrano
Journal:  Parasitol Res       Date:  2013-09-12       Impact factor: 2.289

Review 2.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 3.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.

Authors:  Christopher A Rice; Beatrice L Colon; Mehmet Alp; Hakan Göker; David W Boykin; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

Review 5.  Naegleria fowleri: pathogenesis, diagnosis, and treatment options.

Authors:  Eddie Grace; Scott Asbill; Kris Virga
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

6.  Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.

Authors:  Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-03-11       Impact factor: 5.854

7.  Opportunistic free-living amoebal pathogens.

Authors:  Mohammad Ridwane Mungroo; Naveed Ahmed Khan; Sutherland Maciver; Ruqaiyyah Siddiqui
Journal:  Pathog Glob Health       Date:  2021-10-02       Impact factor: 3.735

8.  In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.

Authors:  Alexandre Taravaud; Philippe M Loiseau; Sébastien Pomel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-09-08       Impact factor: 4.077

9.  The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.

Authors:  Brian Shing; Seema Singh; Larissa M Podust; James H McKerrow; Anjan Debnath
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 10.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.